Bhaskar Anand - Oct 21, 2025 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Accounting Officer
Signature
/s/ Bhaskar Anand
Stock symbol
SMMT
Transactions as of
Oct 21, 2025
Transactions value $
$499,983
Form type
4
Date filed
10/23/2025, 04:11 PM
Previous filing
Sep 19, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Anand Bhaskar Chief Accounting Officer C/O SUMMIT THERAPEUTICS INC., 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI /s/ Bhaskar Anand 2025-10-23 0001890784

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Award $500K +26.7K +20.05% $18.74 160K Oct 21, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of October 21, 2025, pursuant to which the Issuer agreed to sell shares of common stock to the Reporting Person and certain other parties at a purchase price of $18.74 per share. The transaction is anticipated to close on or about October 23, 2025.
F2 Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan.